Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Posted
8/21/18
Assistance Listing Number
93.084
Overview
Grant Opportunities
1
Grant Awards
64
Federal Agency
Centers for Disease Control and Prevention
Applicant Types
Not listed
Beneficiary Types
Not listed
Additional Information
Not listed
Popular Federal Grant Opportunities
Not listed
Popular Federal Grant Awards
Not listed
Name
Description
Awardee
Assistance Type
Dollars Obligated
(Click to sort descending)
Award Date
(Click to sort descending)
Updated At
(Click to sort descending)
U54CK000481
CHICAGO PREVENTION AND INTERVENTION EPICENTER II (CPIE-II)
Rush University Medical Center
Cooperative Agreement
$10.3m
7/1/16
12/30/22
U01CK000539
EVALUATION OF CLINICAL INTERVENTIONS, SURVEILLANCE, AND ECOLOGICAL FACTORS THAT INFLUENCE THE BURDEN OF HUMAN MONKEYPOX IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC)
Kinshasa School Of Public Health
Cooperative Agreement
$3.7m
9/30/17
9/20/23
R43CK000521
POINT OF CARE DEVICE FOR REDUCING OVERUSE OF ANTIBIOTICS IN POTENTIALLY SEPTIC HOSPITAL POPULATIONS
Prenosis, Inc.
Project Grant
$150.0k
9/1/17
9/30/19
U01CK000437
SENTINEL ENHANCED DENGUE SURVEILLANCE SYSTEM (SEDSS) SITES TO EVALUATE THE EPIDEMIOLOGY AND PREVENTION OF DENGUE AND OTHER ACUTE FEBRILE ILLNESSES IN
Ponce Medical School Foundation Inc.
Cooperative Agreement
$7.3m
9/1/15
9/15/21
NU2GGH002463
REDUCING THE BURDEN OF PARASITIC INFECTIONS IN THE UNITED STATES THROUGH EVIDENCE-BASED PREVENTION AND CONTROL ACTIVITIES - CHAGAS EDUCATION FOR ESSENTIAL PROVIDERS
Trustees Of Boston University
Cooperative Agreement
$950.0k
9/30/20
3/19/24
Name
Description
Solicitation Number
Federal Agency
Due Date
(Click to sort descending)
Posted Date
(Click to sort descending)
PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Forecast - This Notice is to inform the eligible United States small business concerns of the reissuance of the Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. When reissued, these FOAs will continue to utilize the R41/R42 and R43/44 grant mechanisms. Modifications to these FOAs will be the inclusion of new and revised research priorities. NIH, CDC, and FDA Institutes and Centers likely to participate in one or more of the FOAs include the following: National Institutes of Health (NIH) National Cancer Institute (NCI) National Eye Institute (NEI) National Heart, Lung, and Blood Institute (NHLBI) National Human Genome Research Institute (NHGRI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute on Drug Abuse (NIDA) National Institute of Environmental Health Sciences (NIEHS) National Institute of General Medical Sciences (NIGMS) National Institute of Mental Health (NIMH) National Institute of Neurological Disorders and Stroke (NINDS) National Institute of Nursing Research (NINR) National Institute on Minority Health and Health Disparities (NIMHD) National Library of Medicine (NLM) National Center for Complementary and Integrative Health (NCCIH) National Center for Advancing Translational Sciences (NCATS) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP) Centers for Disease Control (CDC) Center for Global Health (CGH/CDC) National Center on Birth Defects and Developmental Disabilities (NCBDDD/CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP/CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID/CDC) National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP/CDC) National Center for Immunization and Respiratory Diseases (NCIRD/CDC) National Center for Injury Prevention and Control (NCIPC/CDC) National Institute for Occupational Safety and Health (NIOSH/CDC) National Center for Environmental Health (NCEH/CDC) Center for Preparedness and Response (CPR/CDC) Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER/FDA) Center for Drug Evaluation and Research (CDER/FDA) Center for Food Safety and Applied Nutrition (CFSAN/FDA) Center for Devices and Radiological Health (CDRH/FDA) Center for Veterinary Medicine (CVM/FDA) Office of Critical Path Programs (CPI/FDA) Office of Orphan Products Development (OOPD/FDA) This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
PA-21-260
Department of Health and Human Services National Institutes of Health
4/5/22
4/6/21